Family physicians can help their low-income and uninsured adult patients in need of vaccinations get free vaccines through a new patient assistance program offered by Merck and Co. Inc.
The program is available through licensed health care prescribers to patients who
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Free Adult Vaccines Available Through Patient Assistance Program
By News Staff
- are age 19 or older;
- reside in the United States (U.S. citizenship is not required);
- have no health insurance coverage; and
- have an annual household income less than $19,600 for individuals, $26,500 for couples, or $40,000 for a family of four.
According to information on the Merck Web site, exceptions may be made for patients deemed to have a financial or medical hardship.
Patients can complete the application form, which is available on the Web site, in their physician's office. The physician then can fax the forms directly to Merck, where applications will be processed in 10 minutes or less. The quick turnaround time will enable patients to receive their vaccines at the time of the office visit.
The application must be approved before administration of the vaccine to qualify for the program.
The program comprises all of Merck's adult vaccines:
Patients can complete the application form, which is available on the Web site, in their physician's office. The physician then can fax the forms directly to Merck, where applications will be processed in 10 minutes or less. The quick turnaround time will enable patients to receive their vaccines at the time of the office visit.
The application must be approved before administration of the vaccine to qualify for the program.
The program comprises all of Merck's adult vaccines:
- Gardasil® (quadrivalent human papillomavirus, types 6, 11, 16, 18 recombinant vaccine, investigational);
- M-M-R® II (measles, mumps and rubella virus vaccine live);
- Pneumovax® 23 (pneumococcal vaccine polyvalent);
- Recombivax HB® (Hepatitis B vaccine, recombinant);
- Vaqta® (Hepatitis A vaccine, inactivated);
- Varivax® (varicella virus vaccine live, Oka/Merck); and
- Zostavax® (zoster vaccine live, Oka/Merck).
"Removing financial barriers to access to life-saving vaccines for poorer adults is important," says Walter Orenstein, M.D., director of the Emory Program for Vaccine Policy and Development and associate director of the Emory Vaccine Center, on the Web site. "This program is a bold step to try to assure that lower-income adults can receive the benefits vaccines have to offer."
Questions? Call (800) 293-3881 Monday through Friday from 8 a.m. to 8 p.m. EST for additional information about the program.
Questions? Call (800) 293-3881 Monday through Friday from 8 a.m. to 8 p.m. EST for additional information about the program.
Share this on AAFP Connection
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Health of the Public
Study: PPI Does Not Routinely Improve Asthma Control
Recalled Oral Contraceptives Pose Pregnancy Risk
CDC to Fund 2D Vaccine Barcoding Pilot
2012 Immunization Schedules Reflect Multiple Changes
Study: Cognitive Decline Detected in Middle-aged Adults
CDC Toolkit Can Help Clinicians Fight Norovirus Infection
Patient-Centered Care Linked to Lower Mortality
Study: Inappropriate Cancer Screenings Continue
Novartis Manufacturing Plant Closes After Drug Mix-ups
FDA Announces Classwide REMS for TIRF Medications
New Infants' Acetaminophen Products Hit Store Shelves
Avoid Environmental Factors Linked to Breast Cancer
Risk for Thrombosis Prompts REMS for Rivaroxaban
Common Drugs Implicated in Most Emergency Hospitalizations
CDC Launches Campaign for Child Medication Safety
HHS Blocks Expanded OTC Access to Plan B
Push Is On to Vaccinate Pregnant, Postpartum Women
FDA Committee Votes to Broaden PCV13 Indication
AAFP Foundation Program Aims to Fight Chronic Disease
NIAAA Alcohol Screening Guide Targets Teens
Walgreens, AAFP Launch Flu Vaccine Pilot in Five States
Helping Patients Quit Smoking Starts With a Question
Trilipix Efficacy in Question, Says FDA
USPSTF Addresses Skin Cancer, Obesity, Cervical Cancer Screening
AAFP Endorses ACP Guideline on ED
ACIP Recommends Expanded HPV, Hepatitis B Vaccination
Bacterial Contamination Spurs Nasal Spray Recall
CDC Renews Call for PCV13 Vaccination
USPSTF Recommends Against PSA Screening
AAFP Supports HHS' Million Hearts Initiative
FDA Phases Out Primatene Mist Inhalers
AHRQ Guides Explain Benefits, Risks of GERD Treatments
Office Champions Project Nets Smoking Cessation Gains
Multiple Lots of Oral Contraceptives Recalled
New Vaccine Review Finds Few Adverse Events
HPV Vaccination Rates Still Lag, Says CDC
Renal Injury Prompts Reclast Label Changes
High-dose Citalopram Linked to Abnormal Heart Rhythms
AHRQ Sleep Apnea Guides Review Diagnosis, Management
Board Chair Spotlights Breadth of Family Medicine Training
USPSTF Softens Stance on Bladder Cancer Screening
HHS Expands Coverage for Women's Preventive Services
Teledermatology Project Aids Underserved Patients